What does business segments — cost of product revenue mean?

This metric captures the direct costs associated with producing and delivering the pharmaceutical products sold by the segment. It includes expenses such as manufacturing, packaging, and logistics required to bring products to market. Tracking this helps evaluate the gross margin efficiency of the company's commercialized portfolio.

Crinetics Pharmaceuticals CRNX Business Segments — Cost of product revenue

Similar metrics at other companies

BBIOReportable Segment — Cost of Revenue

$9.94M+277%

BMRNReportable Segment — Cost of Sales

$195M+28.7%

MDGLReportable Segment — Cost of Product and Service Sold

$26.85M+495%

NBIXReportable Segment — Cost of revenues

$13.8M+50.0%

INDVReportable Segment — Cost of Sales

$40M-9.1%

OPCHReportable Segment — Cost of Revenue

$949.36M+1.7%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.79B+21.9%

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's business segments — cost of product revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's business segments — cost of product revenue?: Crinetics Pharmaceuticals (CRNX) reported business segments — cost of product revenue of $200K in Q1 2026.
What does business segments — cost of product revenue mean?: This metric captures the direct costs associated with producing and delivering the pharmaceutical products sold by the segment. It includes expenses such as manufacturing, packaging, and logistics required to bring products to market. Tracking this helps evaluate the gross margin efficiency of the company's commercialized portfolio.